Microscopy and Molecular Assay Compared for Schistosomiasis Diagnosis
|
By LabMedica International staff writers Posted on 12 Aug 2015 |
![Image: Eggs of Schistosoma mansoni in an unstained wet mount (Photo courtesy of the CDC – [US] Centers of Disease Control and Prevention). Image: Eggs of Schistosoma mansoni in an unstained wet mount (Photo courtesy of the CDC – [US] Centers of Disease Control and Prevention).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2015-08-12/RLJ-261a.jpg)
Image: Eggs of Schistosoma mansoni in an unstained wet mount (Photo courtesy of the CDC – [US] Centers of Disease Control and Prevention).

Image: The CFX96 Real-Time Polymerase Chain Reaction Detection System (Photo courtesy of Bio-Rad).
The current reference test for the detection of Schistosoma mansoni in endemic areas is stool microscopy based on one or more Kato-Katz stool smears, but this technique is highly observer-dependent and has suboptimal sensitivity.
Polymerase chain reaction (PCR), in a multiplex format, has the some advantages over microscopy, with greater flexibility as a multiplex PCR can detect all Schistosoma and other helminth species at the same time, and at any moment after the stool has been collected.
Scientists at Leiden University Medical Center (the Netherlands) led an international team to compare the performance of stool microscopy with the highly specific real-time polymerase chain reaction (RT-PCR) for the detection and quantification of parasite specific DNA. Microscopy and PCR were performed in a Senegalese community of 197 in an area with high S. mansoni transmission and co-occurrence of S. haematobium, and in 760 Kenyan schoolchildren from an area with comparatively low S. mansoni transmission.
In Senegal, two stool and two urine samples were collected from each participant on consecutive days. From each stool sample, a duplicate 25 mg Kato-Katz slide was prepared for quantitative detection of Schistosoma spp. eggs and qualitative diagnosis of soil transmitted helminths (STHs) Ascaris lumbricoides and Trichuris trichiura by microscopy. A Schistosoma multiplex real-time PCR (Schisto-PCR) was performed on DNA isolated from feces samples. This PCR targets the Schistosoma-specific internal transcriber-spacer-2 (ITS2) sequence of S. mansoni, S. haematobium, and S. intercalatum. Amplification, detection and data analysis were performed with the CFX96 Real-Time System version 1.1 (Bio-Rad; Hercules, CA, USA).
Despite the differences in Schistosoma endemicity the PCR performed very similarly in both areas; 13%–15% more infections were detected by PCR when comparing to microscopy of a single stool sample. Even when two to three stool samples were used for microscopy, PCR on one stool sample detected more infections, especially in people with light-intensity infections and in children from low-risk schools. The low prevalence of soil-transmitted helminthiasis in both populations was confirmed by an additional multiplex PCR.
The authors concluded that the ITS2-based PCR was more sensitive than standard microscopy in detecting Schistosoma spp. This would be particularly useful for S. mansoni detection in low transmission areas, and post-control settings, and as such improve schistosomiasis control programs, epidemiological research, and quality control of microscopy. Moreover, it can be complemented with other multiplex real-time PCRs to detect a wider range of helminths and thus enhance effectiveness of current integrated control and elimination strategies for neglected tropical diseases. The study was published on July 28, 2015, in the journal Public Library of Science Neglected Tropical Diseases.
Related Links:
Leiden University Medical Center
Bio-Rad
Polymerase chain reaction (PCR), in a multiplex format, has the some advantages over microscopy, with greater flexibility as a multiplex PCR can detect all Schistosoma and other helminth species at the same time, and at any moment after the stool has been collected.
Scientists at Leiden University Medical Center (the Netherlands) led an international team to compare the performance of stool microscopy with the highly specific real-time polymerase chain reaction (RT-PCR) for the detection and quantification of parasite specific DNA. Microscopy and PCR were performed in a Senegalese community of 197 in an area with high S. mansoni transmission and co-occurrence of S. haematobium, and in 760 Kenyan schoolchildren from an area with comparatively low S. mansoni transmission.
In Senegal, two stool and two urine samples were collected from each participant on consecutive days. From each stool sample, a duplicate 25 mg Kato-Katz slide was prepared for quantitative detection of Schistosoma spp. eggs and qualitative diagnosis of soil transmitted helminths (STHs) Ascaris lumbricoides and Trichuris trichiura by microscopy. A Schistosoma multiplex real-time PCR (Schisto-PCR) was performed on DNA isolated from feces samples. This PCR targets the Schistosoma-specific internal transcriber-spacer-2 (ITS2) sequence of S. mansoni, S. haematobium, and S. intercalatum. Amplification, detection and data analysis were performed with the CFX96 Real-Time System version 1.1 (Bio-Rad; Hercules, CA, USA).
Despite the differences in Schistosoma endemicity the PCR performed very similarly in both areas; 13%–15% more infections were detected by PCR when comparing to microscopy of a single stool sample. Even when two to three stool samples were used for microscopy, PCR on one stool sample detected more infections, especially in people with light-intensity infections and in children from low-risk schools. The low prevalence of soil-transmitted helminthiasis in both populations was confirmed by an additional multiplex PCR.
The authors concluded that the ITS2-based PCR was more sensitive than standard microscopy in detecting Schistosoma spp. This would be particularly useful for S. mansoni detection in low transmission areas, and post-control settings, and as such improve schistosomiasis control programs, epidemiological research, and quality control of microscopy. Moreover, it can be complemented with other multiplex real-time PCRs to detect a wider range of helminths and thus enhance effectiveness of current integrated control and elimination strategies for neglected tropical diseases. The study was published on July 28, 2015, in the journal Public Library of Science Neglected Tropical Diseases.
Related Links:
Leiden University Medical Center
Bio-Rad
Latest Molecular Diagnostics News
- Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
- Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
- Two-in-One DNA Analysis Improves Diagnostic Accuracy While Saving Time and Costs
- “Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
- New Tool Maps Chromosome Shifts in Cancer Cells to Predict Tumor Evolution
- Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
- Newly-Identified Parkinson’s Biomarkers to Enable Early Diagnosis Via Blood Tests
- New Blood Test Could Detect Pancreatic Cancer at More Treatable Stage
- Liquid Biopsy Could Replace Surgical Biopsy for Diagnosing Primary Central Nervous Lymphoma
- New Tool Reveals Hidden Metabolic Weakness in Blood Cancers
- World's First Blood Test Distinguishes Between Benign and Cancerous Lung Nodules
- Rapid Test Uses Mobile Phone to Identify Severe Imported Malaria Within Minutes
- Gut Microbiome Signatures Predict Long-Term Outcomes in Acute Pancreatitis
- Blood Test Promises Faster Answers for Deadly Fungal Infections
- Blood Test Could Detect Infection Exposure History
- Urine-Based MRD Test Tracks Response to Bladder Cancer Surgery
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







